Selskabets formål er at drive handelsvirksomhed med farmaceutiske produkter, herunder udvikling, salg, distribution og markedsføring af farmaceutiske produkter og dermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 6 mio. | 3.8 mio. | 39.9 mio. | 8.1 mio. | 12 | |
CVR: 32287824
Secondary names: NORDMEDICA INTERNATIONAL A/S, Atnahs Pharma Nordics A/S, Pharmanovia Nordics A/S
Previous names: NMAS A/S, NORDMEDICA INTERNATIONAL A/S, PHARMANOVIA A/S
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Mohammad Muqtadir Samy joined the board
Amit Vijaykumar Patel left the board
Mohammad Muqtadir Samy left the board
Twan Johannes Anna Nouwen joined the board
Mohammad Muqtadir Samy joined the board
Christoph Michael Habereder joined the board
Santsagar Patel left the board
CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB appointed as auditor
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB resigned as auditor
James Sang Bum Lee left the board
Companies in the same industry and area
companydata.dk